Medications for BPH: An Introduction
Since the early 1990s, millions of American men with mild-to-moderate
BPH symptoms have chosen medications for BPH over surgery as their approach to treating an
enlarged prostate.
There are two main types of medications for BPH: alpha-blockers and 5 alpha-reductase inhibitors. Alpha-blockers relax muscles near the prostate while 5 alpha-reductase inhibitors shrink the prostate gland.
There is evidence that taking both drugs together for BPH treatment may be more beneficial than taking either drug alone.
Medications for BPH: Alpha-Blockers
Alpha-blockers used as
enlarged prostate treatment help relax muscles near the prostate to relieve pressure and let urine flow more freely, but they don't shrink the size of the prostate. For many men, these medications for BPH can improve urine flow and reduce the
enlarged prostate symptoms within days.
Possible side effects of these medications for BPH include:
Medications for BPH: 5 Alpha-Reductase Inhibitors
5 alpha-reductase inhibitors, known as
finasteride or
dutasteride, shrink the prostate. These medications for BPH relieve symptoms by blocking an enzyme that acts on the male hormone testosterone to boost organ growth. When the enzyme is blocked, growth slows down. This helps to:
- Shrink the prostate
- Reduce blockage
- Limit the need for BPH surgery.
Taking this type of medication for BPH for at least 6 months to 1 year can increase urine flow and reduce the symptoms of BPH. It seems to work best for men with very large prostates. Patients must continue to take the drug to prevent their symptoms from coming back. This drug is also used to treat baldness in men (
Propecia®).
5 alpha-reductase inhibitors can cause the following side effects in a small percentage of men:
- Decreased interest in sex
- Trouble getting or keeping an erection
- Smaller amount of semen with ejaculation.
It is important to note that taking this drug can lower your prostate-specific antigen (PSA) test levels. There is also evidence that finasteride lowers the risk of getting
prostate cancer, but whether it lowers the risk of dying from prostate cancer is still unclear.